| Heart Bypass Drug May Need 'Difference-Finding' Trial, FDA Says - Internal Medicine News Digital Network |
|
|
Internal Medicine News Digital Network The FDA's Cardiovascular and Renal Drugs Advisory Committee will likely deliberate on the required size of a clinical study for Portola Pharmaceuticals' |